ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,947Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 208

$1.12M Total Retail Price of All Prescriptions

Rank: 11 out of 208

635 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 6,184 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

52% of this provider’s prescriptions were for brand-name drugs, compared to an average of 51%.

Prescription Price

$125 was the average price of a prescription from this provider, compared to $143 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SYNTHROID 1,010 698 1 2
LEVOTHYROXINE SODIUM 676 469 2 1
METFORMIN HCL ER 511 349 3 13
PEN NEEDLE 373 296 4 3
SIMVASTATIN 238 163 5 6
LISINOPRIL 213 165 6 14
INSULIN SYRINGE 193 94 7 9
LANTUS SOLOSTAR 187 123 8 5
GLIMEPIRIDE 181 134 9 10
METHIMAZOLE 170 125 10 17
ATORVASTATIN CALCIUM 170 110 10 15
NOVOLOG 167 91 12 18
NATEGLINIDE 164 124 13 56
HUMALOG MIX 75-25 160 133 14 25
JANUVIA 153 143 15 12
TRILIPIX 147 83 16 90
LOVAZA 147 64 16 39
LANTUS 139 95 18 7
METFORMIN HCL 134 73 19 4
NOVOLOG FLEXPEN 130 90 20 11
ONGLYZA 124 90 21 73
CRESTOR 119 78 22 31
FENOFIBRATE 118 69 23 43
NOVOLOG MIX 70-30 FLEXPEN 112 104 24 21
LEVEMIR FLEXPEN 111 84 25 19
HUMALOG 110 66 26 8
ACTOS 107 94 27 22
LIOTHYRONINE SODIUM 103 56 28 108
WELCHOL 100 74 29 105
ACARBOSE 90 56 30 72
LEVEMIR 87 47 31 55
NIASPAN 85 37 32 52
HYDROCHLOROTHIAZIDE 76 55 33 29
KOMBIGLYZE XR 73 49 34 116
LOSARTAN POTASSIUM 71 55 35 34
BYETTA 70 43 36 41
DIOVAN 66 39 37 42
GLYBURIDE 56 50 R 38 51
GLIPIZIDE 54 43 39 23
HYDROCORTISONE 53 32 40 40
LIPITOR 51 35 41 67
SPIRONOLACTONE 51 17 41 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.